Sort
40,608 grants matching “prostate cancer”
Paul Calabresi Program in Clinical-Translational Research at Mayo Clinic
$665,657Lynn C. Hartmann · Mayo Clinic Rochester · K12 · FY2007 · CA
BIOLOGICAL AND GENOMIC DIFFERENCES OF ERG ONCOPROTEIN-STRATIFIED PROSTATE CANCERS FROM AFRICAN AND CAUCASIAN AMERICANS
$665,650The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. · · FY2013 · Department of the Army
Biomarkers of Hormone Therapy Response in a Multicenter Prostate Cancer Trial
$665,642Amir Goldkorn · University Of Southern California · R01 · FY2017 · CA
A Multilevel Intervention to Increase the Participation of African Americans in Prostate Cancer Clinical Trials
$665,635Susan S. Eggly · Wayne State University · R01 · FY2018 · CA
TRACKING ORIGINS OF PROSTATE CANCER: AN INNOVATIVE IN VIVO MODELING
$665,577Wake Forest University Health Sciences · · FY2010 · Department of Defense
Multi-Modality Quantitative Imaging for Evaluation of Response to Cancer Therapy
$665,567Eric C. Frey · Johns Hopkins University · U01 · FY2018 · CA
CHEMISTRY AND BIOLOGY OF PLATINUM ANTICANCER DRUGS
$665,514Stephen J Lippard · Massachusetts Institute Of Technology · R37 · FY2007 · CA
Inorganics as Early Life Carcinogens
$665,404Michael Waalkes · National Institute Of Environmental Health Sciences · ZIA · FY2010 · ES
Tissue ProcessingSequencing Core
$665,306Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Elucidation of the mechanisms by which cells recognize and respond to different levels of androgens
$665,035Donald P McDonnell · Duke University · R01 · FY2022 · CA
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer
$664,854Moran Amit · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · DE
Administrative Supplement to MD Anderson Cancer Center Prostate Cancer SPORE
$664,838Christopher J. Logothetis · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 2 of 3)
$664,819Harold L Moses · Vanderbilt University · U54 · FY2015 · CA
Systematic evaluation of toxicity and therapeutic efficacy in CD46 directed radioligand therapy
$664,448Robert Richard Flavell · University Of California, San Francisco · R01 · FY2025 · CA
Quantifying and Characterizing the shared genetic contribution to common cancers
$664,391Sara Lindstroem · University Of Washington · U01 · FY2016 · CA
Characterization Of Novel Chemokine Receptors In Lymphocytes
$664,379Joshua M Farber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
IMPROVED MRI/MRSI FOR BIOPSY GUIDANCE OF PROSTATE CANCER
$664,275University Of California San Francisco · R33 · FY2001 · CA
METABOLOMIC PROFILING OF PROSTATE CANCER PROGRESSION DURING ACTIVE SURVEILLANCE
$664,264The Johns Hopkins University · · FY2011 · Department of Defense
Systematic evaluation of toxicity and therapeutic efficacy in CD46 directed radioligand therapy
$664,250Robert Richard Flavell · University Of California, San Francisco · R01 · FY2023 · CA
Theranostic gold nanoparticles for imaged-guided radical prostatectomy and PDT ablation
$664,240James Peter Basilion · Case Western Reserve University · R01 · FY2018 · EB
Theranostic gold nanoparticles for imaged-guided radical prostatectomy and PDT ablation
$664,240James Peter Basilion · Case Western Reserve University · R01 · FY2017 · EB
Genome-wide Pleiotropy Scan across Multiple Cancers
$664,225John S Witte · University Of California, San Francisco · R01 · FY2016 · CA
PLCO EEMS and Extended Follow Up
$664,206Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
Project 1: Phospholipid Remodeling in Ferroptosis and Cancer
$664,168Xuejun Jiang · Sloan-Kettering Inst Can Research · P01 · FY2025 · CA
Active surveillance and patient reported outcomes in a diverse population of prostate cancer patients
$664,142Scarlett L Gomez · University Of California, San Francisco · R01 · FY2017 · CA